Holen Sie sich die Stockscreener-App
10.49
15.95%
-1.99
Handel nachbörslich:
10.47
-0.02
-0.19%
Schlusskurs vom Vortag:
$12.48
Offen:
$12.49
24-Stunden-Volumen:
2.86M
Relative Volume:
2.32
Marktkapitalisierung:
$559.65M
Einnahmen:
$1.02B
Nettoeinkommen (Verlust:
$-757.20M
KGV:
-0.7107
EPS:
-14.76
Netto-Cashflow:
$-257.90M
1W Leistung:
+8.26%
1M Leistung:
+14.64%
6M Leistung:
+104.09%
1J Leistung:
+15.02%
1-Tages-Spanne:
$10.16
$12.65
1-Wochen-Bereich:
$9.21
$13.41
52-Wochen-Spanne:
$4.02
$13.41
Emergent Biosolutions Inc Stock (EBS) Company Profile
Firmenname
Emergent Biosolutions Inc
Sektor
Telefon
240-631-3200
Adresse
300 PROFESSIONAL DR, GAITHERSBURG, MD
Vergleichen Sie EBS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
EBS
Emergent Biosolutions Inc
|
10.49 | 655.45M | 1.02B | -757.20M | -257.90M | -14.76 |
|
ZTS
Zoetis Inc
|
144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Emergent Biosolutions Inc Stock (EBS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-30 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-08-22 | Eingeleitet | Rodman & Renshaw | Buy |
| 2024-03-07 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-11-20 | Fortgesetzt | JP Morgan | Underweight |
| 2023-08-29 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2023-04-10 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2023-03-17 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-11-10 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-04-29 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2022-01-20 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2021-11-08 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2021-05-05 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Eingeleitet | The Benchmark Company | Buy |
| 2021-02-24 | Hochstufung | Chardan Capital Markets | Neutral → Buy |
| 2021-02-19 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2021-01-08 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-09-14 | Fortgesetzt | JP Morgan | Neutral |
| 2020-07-31 | Bestätigt | Chardan Capital Markets | Buy |
| 2019-09-12 | Eingeleitet | Guggenheim | Buy |
| 2019-09-04 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2018-11-02 | Hochstufung | Goldman | Neutral → Buy |
| 2018-08-03 | Bestätigt | Chardan Capital Markets | Buy |
| 2018-06-13 | Eingeleitet | Argus | Buy |
| 2018-04-25 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2018-01-24 | Eingeleitet | Goldman | Neutral |
| 2018-01-16 | Bestätigt | Chardan Capital Markets | Buy |
| 2016-06-28 | Bestätigt | Singular Research | Buy |
| 2016-04-15 | Eingeleitet | Chardan Capital Markets | Buy |
| 2016-03-28 | Eingeleitet | Singular Research | Buy |
| 2016-02-19 | Eingeleitet | Wells Fargo | Outperform |
| 2014-05-15 | Eingeleitet | Summer Street Research | Buy |
| 2011-05-31 | Bestätigt | WBB Securities | Strong Buy |
| 2011-01-10 | Bestätigt | Wedbush | Outperform |
| 2010-11-05 | Bestätigt | Wedbush | Outperform |
| 2010-08-18 | Hochstufung | WBB Securities | Buy → Strong Buy |
| 2010-08-06 | Bestätigt | Caris & Company | Buy |
Alle ansehen
Emergent Biosolutions Inc Aktie (EBS) Neueste Nachrichten
Emergent BioSolutions Inc.'s (NYSE:EBS) High Institutional Ownership Speaks for Itself as Stock Continues to Impress, up 29% Over Last Week - 富途牛牛
Will Emergent BioSolutions Inc. stock sustain high P E ratiosGap Down & Long-Term Investment Growth Plans - newser.com
Will Emergent BioSolutions Inc. stock deliver consistent dividendsWeekly Trading Summary & Consistent Return Investment Signals - newser.com
Visual analytics tools that track Emergent BioSolutions Inc. performanceEarnings Risk Summary & Smart Swing Trading Alerts - newser.com
How Emergent BioSolutions Inc. (ER4) stock behaves in tightening cyclesWeekly Stock Report & High Return Trade Guides - newser.com
Why Emergent BioSolutions Inc. (ER4) stock is listed among top recommendations2025 Short Interest & Long-Term Safe Investment Plans - newser.com
Why Emergent BioSolutions Inc. (ER4) stock remains top ratedQuarterly Profit Report & Reliable Intraday Trade Alerts - newser.com
Will Emergent BioSolutions Inc. stock justify high valuation2025 Major Catalysts & Real-Time Volume Spike Alerts - newser.com
Wolverine Asset Management LLC Raises Stock Position in Emergent Biosolutions Inc. $EBS - MarketBeat
Is Emergent BioSolutions Inc. stock dividend yield sustainableJuly 2025 Highlights & Consistent Growth Stock Picks - newser.com
Published on: 2025-11-03 02:38:18 - newser.com
How Emergent BioSolutions Inc. stock benefits from tech adoptionWeekly Volume Report & Weekly High Conviction Ideas - newser.com
Published on: 2025-11-02 23:34:34 - newser.com
Combining price and volume data for Emergent BioSolutions Inc.Portfolio Profit Report & Growth Oriented Trade Recommendations - newser.com
Chart based exit strategy for Emergent BioSolutions Inc.2025 Buyback Activity & Weekly Return Optimization Alerts - newser.com
Reversal indicators forming on Emergent BioSolutions Inc. stockQuarterly Profit Report & Reliable Trade Execution Plans - newser.com
Published on: 2025-11-02 23:01:50 - newser.com
Will Emergent BioSolutions Inc. stock return to pre crisis levelsMarket Sentiment Review & Fast Gain Stock Trading Tips - newser.com
Emergent BioSolutions (EBS) Is Up 28.1% After Strong Q3 Results and Raised 2025 Guidance Has the Bull Case Changed? - Yahoo Finance
Applying Wyckoff theory to Emergent BioSolutions Inc. stock2025 Top Gainers & Verified Entry Point Signals - newser.com
Published on: 2025-11-02 12:46:41 - newser.com
Published on: 2025-11-02 12:32:07 - newser.com
Will Emergent BioSolutions Inc. benefit from macro trendsJuly 2025 Institutional & High Conviction Buy Zone Picks - newser.com
Emergent BioSolutions Hits New 52-Week High of $13.41, Up 100.94% - Markets Mojo
Why Emergent BioSolutions Inc. stock remains resilient2025 Top Gainers & Daily Price Action Insights - newser.com
Emergent Biosolutions (NYSE:EBS) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat
Is Emergent BioSolutions Inc. a candidate for recovery playVolume Spike & Reliable Price Action Trade Plans - newser.com
Emergent Biosolutions (NYSE:EBS) Hits New 52-Week HighHere's Why - MarketBeat
Published on: 2025-11-01 03:39:59 - newser.com
Published on: 2025-11-01 02:24:00 - newser.com
Emergent Biosolutions Inc. (EBS) Soars to 52-Week High, Time to Cash Out? - sharewise.com
Will breakout in Emergent BioSolutions Inc. lead to full recoveryTreasury Yields & Advanced Swing Trade Entry Alerts - newser.com
Understanding Emergent BioSolutions Inc.’s price movementWeekly Market Report & Fast Moving Stock Watchlists - newser.com
Emergent BioSolutions’ Earnings Call Highlights Strong Growth - The Globe and Mail
Biodefense Market to Attain USD 32.87 Billion by 2034, Driven by Biotech Advancements and Government Funding - GlobeNewswire Inc.
Emergent Biosolutions (NYSE:EBS) Shares Gap Up After Strong Earnings - MarketBeat
Emergent BioSolutions Raises Full-Year Revenue Guidance - MSN
Why Emergent BioSolutions Inc. stock could rally in 20252025 Retail Activity & Real-Time Volume Analysis - newser.com
Why millennials buy Emergent BioSolutions Inc. (ER4) stockJuly 2025 Market Mood & Precise Buy Zone Tips - newser.com
Is Emergent BioSolutions Inc. stock resilient in recession scenarios2025 Pullback Review & Long Hold Capital Preservation Tips - newser.com
Analyzing Emergent BioSolutions Inc. with multi timeframe charts2025 Market WrapUp & Expert Approved Trade Ideas - newser.com
What sentiment indicators say about Emergent BioSolutions Inc. stock2025 Volume Leaders & Reliable Entry Point Alerts - newser.com
symbol__ Stock Quote Price and Forecast - CNN
Emergent BioSolutions (EBS): One-Off $42.1M Loss Clouds Return to Profit, Tests Bullish Narratives - Sahm
Finanzdaten der Emergent Biosolutions Inc-Aktie (EBS)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.35%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):